Wednesday November 20, 2019

India tops in development of Stem cell treatment, also it can be a pathbreaking Therapy for Diabetes, Autism

Stem cell therapy has turned out to be a ray of hope for most patients who are trying to find a cure for incurable diseases

0
//
Doctors operating on a patient (representational image), Pixabay

Jan 18, 2017: Stem cell therapy has turned out to be a ray of hope for most patients who are trying to find a cure for incurable diseases. Researchers and experts believe India has been at the top in the development of stem cell treatment followed by several other countries like China and Japan. However, due to lack of awareness, most people don’t think of stem cell therapy as an option for treating most of the incurable diseases.

One of the major issues that India is battling is increasing incidence of diabetes and autism. According to reports, more than 10 million children in India suffer from autism. About 1 to 1.5 per cent of such children are aged 2-9. Autism by far is a mental condition which is present from early childhood, characterised by great difficulty in communicating and forming relationships with other people and in using language and abstract concepts, and also characterised by weakened social interface, weakened communication and indulging in repetitive behaviour.

Check out NewsGram for latest international news updates.

In the case of diabetes, it is one of the most talked-about diseases across the world and especially in India, but awareness on this is still low. Diabetes generally occurs due to failure or damage of the cells that produce insulin in the pancreas called Beta cells. Diabetes can be classified into 2 types: Type 1 (T1DM) and Type 2 (T2DM).

Stem cells are part of the human body and have the unique ability of naturally finding and repairing the place of damage within. Over the past two decades, it has been made possible to treat T1DM by transplanting islet cells or even whole pancreas from cadaveric donors (allogenic transplantation). Transplants can enable the body to regain control of blood sugar levels so that insulin injections are no longer needed.

Islet transplantations are not very common, because whole pancreas transplants involve major surgery and carry significant risk. Transplants require the immune system to be suppressed so that the new “alien” organ is not rejected. Immuno-suppressant drugs leave the recipient vulnerable to infections and often have side-effects. One of the biggest problems faced by islet transplantation is the lack of donors.

NewsGram brings to you top news around the world today.

This can be overcome by using patient’s own stem cells (autologous transplantation), bypassing all the complications, rejections and side-effects. Research has shown that stem cells present in the patient’s pancreas are able to make new Beta cells. Beta cell progenitors have been found in the pancreas of both rodents and humans; it may be possible to grow islet cells from patient’s existing islet cells. Alternately, mesenchymal stem cells (MSCs) treatment is also being explored. These can be sourced from the patient’s own adipose tissue (fat), umbilical cord, menstrual fluid, bone marrow and the like.

Clinical trials inserting MSCs into Type 1 diabetes patients take advantage of two properties of these cells. Firstly, they have the regenerative potential to repair Beta cells and, secondly, they can modulate the immune system by inhibiting the responses that lead to the auto-immune attack on pancreatic Beta cells. Since these stem cells come from the patient’s own body, there is also no risk of rejection or side-effects. MSCs may be injected intravenously or within the pancreas itself. This approach promotes Beta cell function, thereby reducing or eliminating the requirement for exogenous insulin.

The central government is also planning to curb the growing incidence of diabetes by stringent measures, including higher taxes and stricter advertisement norms to regulate sale of sugar-sweetened beverages and junk food.

Clinical trials are also under way for autism. Experts believe the umbilical cord stem cells are ideal for treating this because they allow doctors to administer uniform doses as they don’t require collection of stem cells from the patient considering it could be a laborious process for child and the parent. Because they are collected right after birth, umbilical cord-derived cells are much more potent than their “older” counterparts like bone marrow-derived cells.

With trials under way, stem cell therapy could be an effective solution in treating autism and Type 1 diabetes rather than harmful drugs. (IANS)

Next Story

Study Says, Early Signs of Diabetes Can be Observed in Children

The study tracked over 4,000 participants of the Children of the 90s study, a birth cohort established in Bristol in the early 1990s

0
Diabetes
The research was conducted among young healthy people who were generally free of type 2 Diabetes and other chronic diseases to see how early in life the effects of diabetes susceptibility become visible. Pixabay

Researchers have found that early signs of adulthood type 2 Diabetes can be seen in children as young as 8 years old.

Type 2 diabetes is most often diagnosed in middle age or later, with its symptoms slowly developing over many years.

“It’s remarkable that we can see signs of adult diabetes in the blood from such a young age, this is about 50 years before it’s commonly diagnosed.

“This is not a clinical study; nearly all participants were free of diabetes and most will not go on to develop it. This is about liability to disease and how genetics can tell us something about how the disease develops,” said study researcher Joshua Bell from the University of Bristol in the UK.

The research was conducted among young healthy people who were generally free of type 2 diabetes and other chronic diseases to see how early in life the effects of diabetes susceptibility become visible.

The study tracked over 4,000 participants of the Children of the 90s study, a birth cohort established in Bristol in the early 1990s.

The researchers combined genetics with an approach called ‘metabolomics’, which involves measuring many small molecules in a blood sample to try and identify patterns that are unique to type 2 diabetes.

According to the findings, the research team analysed 162 pieces of genetic information and combined this with 200 measures of many small molecules in a blood sample, known as metabolics, to identify signs of type 2 diabetes.

Diabetes
Researchers have found that early signs of adulthood type 2 Diabetes can be seen in children as young as 8 years old. Pixabay

Data was taken once in childhood — at 8 years old, twice in adolescence aged 16 and 18 years and once in young adulthood aged 25 years.

They found levels of HDL cholesterol were reduced at age 8, while inflammatory glycoprotein acetyls and amino acids were elevated in 16 and 18 year old teenagers.

These metabolic features could be targeted to prevent young people from going on to develop type 2 diabetes in the future, the researchers said.

ALSO READ: Income Tax Officers Quit Work For Mental Peace

The findings were presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Barcelona. (IANS)